Skip to main content
Erschienen in: World Journal of Surgery 1/2008

01.01.2008

Analysis of Prognostic Factors Influencing Long-term Survival After Hepatic Resection for Metastatic Colorectal Cancer

verfasst von: Marcella Arru, Luca Aldrighetti, Renato Castoldi, Saverio Di Palo, Elena Orsenigo, Marco Stella, Carlo Pulitanò, Francesca Gavazzi, Gianfranco Ferla, Valerio Di Carlo, Carlo Staudacher

Erschienen in: World Journal of Surgery | Ausgabe 1/2008

Einloggen, um Zugang zu erhalten

Abstract

Background

The aim of this study was to analyze the prognostic factors associated with long-term outcome after liver resection for colorectal metastases. The retrospective analysis included 297 liver resections for colorectal metastases.

Methods

The variables considered included disease stage, differentiation grade, site and nodal metastasis of the primary tumor, number and diameter of the lesions, time from primary cancer to metastasis, preoperative carcinoembryonic antigen (CEA) level, adjuvant chemotherapy, type of resection, intraoperative ultrasonography and portal clamping use, blood loss, transfusions, complications, hospitalization, surgical margins status, and a clinical risk score (MSKCC-CRS).

Results

The univariate analysis revealed a significant difference (p < 0.05) in overall 5-year survival rates depending on the differentiation grade, preoperative CEA >5 and >200 ng/ml, diameter of the lesion >5 cm, time from primary tumor to metastases >12 months, MSKCC-CRS >2. The multivariate analysis showed three independent negative prognostic factors: G3 or G4 grade, CEA >5 ng/ml, and high MSKCC-CRS.

Conclusions

No single prognostic factor proved to be associated with a sufficiently disappointing outcome to exclude patients from liver resection. However, in the presence of some prognostic factors (G3–G4 differentiation, preoperative CEA >5 ng/ml, high MSKCC-CRS), enrollment of patients in trials exploring new adjuvant treatments is suggested to improve the outcome after surgery.
Literatur
1.
Zurück zum Zitat Memom MA, Beckingham IJ (2001) Surgical resection of colorectal liver metastases. Colorectal Dis 3:361–373CrossRef Memom MA, Beckingham IJ (2001) Surgical resection of colorectal liver metastases. Colorectal Dis 3:361–373CrossRef
2.
Zurück zum Zitat Chang AE, Schneider PD, Sugarbaker PH, et al. (1987) A prospective randomized trial of regional vs. systemic continuous infusion 5-FU chemotherapy in the treatment of colorectal metastases. Ann Surg 206:685–693PubMedCrossRef Chang AE, Schneider PD, Sugarbaker PH, et al. (1987) A prospective randomized trial of regional vs. systemic continuous infusion 5-FU chemotherapy in the treatment of colorectal metastases. Ann Surg 206:685–693PubMedCrossRef
3.
Zurück zum Zitat Jaffe BM, Donegan WL, Watson F (1968) Factor influencing survival in patients with untreated hepatic metastases. Ann Gynecol Obstet 127:1–11 Jaffe BM, Donegan WL, Watson F (1968) Factor influencing survival in patients with untreated hepatic metastases. Ann Gynecol Obstet 127:1–11
4.
Zurück zum Zitat Bengmark S, Hafstrom L (1969) The natural history of primary and secondary malignant tumors of the liver: the prognosis for patients with hepatic metastases from colonic and rectal carcinoma by laparotomy. Cancer 23:198–202PubMedCrossRef Bengmark S, Hafstrom L (1969) The natural history of primary and secondary malignant tumors of the liver: the prognosis for patients with hepatic metastases from colonic and rectal carcinoma by laparotomy. Cancer 23:198–202PubMedCrossRef
5.
Zurück zum Zitat Glasgow R, Showtack J, Katz P, et al. (1999) The relationship between hospital volume and outcomes of hepatic resection for hepatocellular carcinoma. Arch Surg 134:30–35PubMedCrossRef Glasgow R, Showtack J, Katz P, et al. (1999) The relationship between hospital volume and outcomes of hepatic resection for hepatocellular carcinoma. Arch Surg 134:30–35PubMedCrossRef
6.
Zurück zum Zitat Adam R, Laurent A, Azoulay D, et al. (2000) Two-stage hepatectomy: a planned strategy to treat irresectable liver tumors. Ann Surg 232:777–785PubMedCrossRef Adam R, Laurent A, Azoulay D, et al. (2000) Two-stage hepatectomy: a planned strategy to treat irresectable liver tumors. Ann Surg 232:777–785PubMedCrossRef
7.
Zurück zum Zitat Adam R, Huguet D, Azoulay D, et al. (2003) Hepatic resection after down-staging of unresectable hepatic colorectal metastases. Surg Oncol Clin N Am 12:211–220PubMedCrossRef Adam R, Huguet D, Azoulay D, et al. (2003) Hepatic resection after down-staging of unresectable hepatic colorectal metastases. Surg Oncol Clin N Am 12:211–220PubMedCrossRef
8.
Zurück zum Zitat Elias D, Ouellet JF, Bellon N, et al. (2003) Extrahepatic disease does not contraindicate hepatectomy for colorectal liver metastases. Br J Surg 90:567–574PubMedCrossRef Elias D, Ouellet JF, Bellon N, et al. (2003) Extrahepatic disease does not contraindicate hepatectomy for colorectal liver metastases. Br J Surg 90:567–574PubMedCrossRef
9.
Zurück zum Zitat Inoue M, Ohta M, Iuchi K, et al. (2004) Benefits of surgery for patients with pulmonary metastases from colorectal carcinoma. Ann Thorac Surg 78:238–244PubMedCrossRef Inoue M, Ohta M, Iuchi K, et al. (2004) Benefits of surgery for patients with pulmonary metastases from colorectal carcinoma. Ann Thorac Surg 78:238–244PubMedCrossRef
10.
Zurück zum Zitat Bolton J, Fuhrman M (2000) Survival after resection of multiple bilobar hepatic metastases from colorectal cancer. Ann Surg 7:743–751CrossRef Bolton J, Fuhrman M (2000) Survival after resection of multiple bilobar hepatic metastases from colorectal cancer. Ann Surg 7:743–751CrossRef
11.
Zurück zum Zitat Imamura H, Sano K, Harihara Y, et al. (2003) Complete remission of disease for 5 years following initial and repeat resection of the liver for the removal of 22 metastases of colorectal origin. J Hepatobiliary Pancreat Surg 10:321–324PubMedCrossRef Imamura H, Sano K, Harihara Y, et al. (2003) Complete remission of disease for 5 years following initial and repeat resection of the liver for the removal of 22 metastases of colorectal origin. J Hepatobiliary Pancreat Surg 10:321–324PubMedCrossRef
12.
Zurück zum Zitat Nagakura S, Shirai Y, Wakai T, et al. (2003) An 11-year survivor who underwent ten sequential resections of colonic adenocarcinoma metastases. Hepatogastroenterology 50:1032–1033PubMed Nagakura S, Shirai Y, Wakai T, et al. (2003) An 11-year survivor who underwent ten sequential resections of colonic adenocarcinoma metastases. Hepatogastroenterology 50:1032–1033PubMed
13.
Zurück zum Zitat Petrowsky H, Gonen M, Jarnagin W, et al. (2002) Second liver resections are safe and effective treatment for recurrent hepatic metastases from colorectal cancer: a bi-institutional analysis. Ann Surg 235:863–871PubMedCrossRef Petrowsky H, Gonen M, Jarnagin W, et al. (2002) Second liver resections are safe and effective treatment for recurrent hepatic metastases from colorectal cancer: a bi-institutional analysis. Ann Surg 235:863–871PubMedCrossRef
14.
Zurück zum Zitat Abdalla EK, Vauthey JN, Ellis LM, et al. (2004) Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 239:818–825PubMedCrossRef Abdalla EK, Vauthey JN, Ellis LM, et al. (2004) Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 239:818–825PubMedCrossRef
15.
Zurück zum Zitat Adam R, Pascal G, Azoulay D, et al. (2003) Liver resection for colorectal metastases: the third hepatectomy. Ann Surg 238:871–883PubMedCrossRef Adam R, Pascal G, Azoulay D, et al. (2003) Liver resection for colorectal metastases: the third hepatectomy. Ann Surg 238:871–883PubMedCrossRef
16.
Zurück zum Zitat Terminology Committee of the International Hepato-Pancreato-Biliary Association (2000) IHPBA Brisbane 2000 Terminology of Liver Anatomy & Resections. HPB 2:333–339 Terminology Committee of the International Hepato-Pancreato-Biliary Association (2000) IHPBA Brisbane 2000 Terminology of Liver Anatomy & Resections. HPB 2:333–339
17.
Zurück zum Zitat Fong Y, Fortner J, Sun RL, et al. (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230:309–318; discussion 318–321PubMedCrossRef Fong Y, Fortner J, Sun RL, et al. (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230:309–318; discussion 318–321PubMedCrossRef
18.
Zurück zum Zitat Ercolani G, Grazi GL, Ravaioli M, et al. (2002) Liver resection for multiple colorectal metastases: influence of parenchymal involvement and total tumor volume, vs number or location, on long-term survival. Arch Surg 137:1187–1192PubMedCrossRef Ercolani G, Grazi GL, Ravaioli M, et al. (2002) Liver resection for multiple colorectal metastases: influence of parenchymal involvement and total tumor volume, vs number or location, on long-term survival. Arch Surg 137:1187–1192PubMedCrossRef
19.
Zurück zum Zitat Doci R, Gennari L, Bignami P, et al. (1995) Morbidity and mortality after hepatic resection of metastases from colorectal cancer. Br J Surg 82:377–381PubMedCrossRef Doci R, Gennari L, Bignami P, et al. (1995) Morbidity and mortality after hepatic resection of metastases from colorectal cancer. Br J Surg 82:377–381PubMedCrossRef
20.
Zurück zum Zitat Ferrero A, Polastri R, Muratore A, et al. (2004) Extensive resections for colorectal liver metastases. J Hepatobiliary Pancreat Surg 11:92–96PubMedCrossRef Ferrero A, Polastri R, Muratore A, et al. (2004) Extensive resections for colorectal liver metastases. J Hepatobiliary Pancreat Surg 11:92–96PubMedCrossRef
21.
Zurück zum Zitat Nuzzo G, Giuliante F, Giovannini I, et al. (1997) Resection of hepatic metastases from colorectal cancer. Hepatogastroenterology 44:751–759PubMed Nuzzo G, Giuliante F, Giovannini I, et al. (1997) Resection of hepatic metastases from colorectal cancer. Hepatogastroenterology 44:751–759PubMed
22.
Zurück zum Zitat Nordlinger B, Guiguet M, Vaillant JC, et al. (1996) Surgical resection of colorectal carcinoma metastases to the liver: a prognostic scoring system to improve selection, based on 1568 patients. Cancer 77:1254–1262PubMedCrossRef Nordlinger B, Guiguet M, Vaillant JC, et al. (1996) Surgical resection of colorectal carcinoma metastases to the liver: a prognostic scoring system to improve selection, based on 1568 patients. Cancer 77:1254–1262PubMedCrossRef
23.
Zurück zum Zitat De Santibanes E, Lassalle FB, McCormack L, et al. (2002) Simultaneous colorectal and hepatic resections for colorectal cancer: postoperative and longterm outcomes. J Am Coll Surg 195:196–202PubMedCrossRef De Santibanes E, Lassalle FB, McCormack L, et al. (2002) Simultaneous colorectal and hepatic resections for colorectal cancer: postoperative and longterm outcomes. J Am Coll Surg 195:196–202PubMedCrossRef
24.
Zurück zum Zitat Yamada H, Kondo S, Okushiba S, et al. (2001) Analysis of predictive factors for recurrence after hepatectomy for colorectal liver metastases. World J Surg 25:1129–1133PubMedCrossRef Yamada H, Kondo S, Okushiba S, et al. (2001) Analysis of predictive factors for recurrence after hepatectomy for colorectal liver metastases. World J Surg 25:1129–1133PubMedCrossRef
25.
Zurück zum Zitat Seifert JK, Bottger TC, Weigel TF, et al. (2000) Prognostic factors following liver resection for hepatic metastases from colorectal cancer. Hepatogastroenterology 47:239–246PubMed Seifert JK, Bottger TC, Weigel TF, et al. (2000) Prognostic factors following liver resection for hepatic metastases from colorectal cancer. Hepatogastroenterology 47:239–246PubMed
26.
Zurück zum Zitat Laurent C, Sa Cunha A, Coudere P, et al. (2003) Influence of postoperative morbidity on long-term survival following liver resection for colorectal metastases. Br J Surg 90:1131–1136PubMedCrossRef Laurent C, Sa Cunha A, Coudere P, et al. (2003) Influence of postoperative morbidity on long-term survival following liver resection for colorectal metastases. Br J Surg 90:1131–1136PubMedCrossRef
27.
Zurück zum Zitat Yamada H, Katoh H, Kondo S, et al. (2002) Mesenteric lymph nodes status influencing survival and recurrence pattern after hepatectomy for colorectal liver metastases. Hepatogastroenterology 49:1265–1268PubMed Yamada H, Katoh H, Kondo S, et al. (2002) Mesenteric lymph nodes status influencing survival and recurrence pattern after hepatectomy for colorectal liver metastases. Hepatogastroenterology 49:1265–1268PubMed
28.
Zurück zum Zitat Choti MA, Sitzmann JV, Tiburi MF, et al. (2002) Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 235:759–766PubMedCrossRef Choti MA, Sitzmann JV, Tiburi MF, et al. (2002) Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 235:759–766PubMedCrossRef
29.
Zurück zum Zitat Yamamoto J, Sugihara K, Kosuge T, et al. (1995) Pathologic support for limited hepatectomy in the treatment of liver metastases from colorectal cancer. Ann Surg 221:74–78PubMedCrossRef Yamamoto J, Sugihara K, Kosuge T, et al. (1995) Pathologic support for limited hepatectomy in the treatment of liver metastases from colorectal cancer. Ann Surg 221:74–78PubMedCrossRef
30.
Zurück zum Zitat Imamura H, Matsuyama Y, Shimada R, et al. (2001) A study of factors influencing prognosis after resection of hepatic metastases from colorectal and gastric carcinoma. Am J Gastroenterol 96:3178–3184PubMedCrossRef Imamura H, Matsuyama Y, Shimada R, et al. (2001) A study of factors influencing prognosis after resection of hepatic metastases from colorectal and gastric carcinoma. Am J Gastroenterol 96:3178–3184PubMedCrossRef
31.
Zurück zum Zitat Douillard JY, Cunningham D, Roth AD, et al. (2000) Irinotecan combined with fluorouracil compared with fluorouracil alone as first line treatment for metastatic colorectal cancer: a multicentric randomised trial. Lancet 355:1041–1047PubMedCrossRef Douillard JY, Cunningham D, Roth AD, et al. (2000) Irinotecan combined with fluorouracil compared with fluorouracil alone as first line treatment for metastatic colorectal cancer: a multicentric randomised trial. Lancet 355:1041–1047PubMedCrossRef
32.
Zurück zum Zitat De Gramont A, Figer M, Seymour M, et al. (2000) Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 18:2938–2947PubMed De Gramont A, Figer M, Seymour M, et al. (2000) Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 18:2938–2947PubMed
33.
Zurück zum Zitat Ercolani G, Grazi GL, Ravaioli M, et al. (2004) The role of lymphadenectomy for liver tumors: further considerations on the appropriateness of treatment strategy. Ann Surg 239:202–209PubMedCrossRef Ercolani G, Grazi GL, Ravaioli M, et al. (2004) The role of lymphadenectomy for liver tumors: further considerations on the appropriateness of treatment strategy. Ann Surg 239:202–209PubMedCrossRef
34.
Zurück zum Zitat Laurent C, Sa Cunha A, Rullier E, et al. (2004) Impact of microscopic hepatic lymph node involvement on survival after resection of colorectal liver metastasis. J Am Coll Surg 198:884–891PubMedCrossRef Laurent C, Sa Cunha A, Rullier E, et al. (2004) Impact of microscopic hepatic lymph node involvement on survival after resection of colorectal liver metastasis. J Am Coll Surg 198:884–891PubMedCrossRef
35.
Zurück zum Zitat Imamura H, Seyama Y, Kokudo N, et al. (2004) Single and multiple resections of multiple hepatic metastases of colorectal origin. Surgery 135:508–517PubMedCrossRef Imamura H, Seyama Y, Kokudo N, et al. (2004) Single and multiple resections of multiple hepatic metastases of colorectal origin. Surgery 135:508–517PubMedCrossRef
36.
Zurück zum Zitat Rosen CB, Nagorney DM, Taswell HF, et al. (1992) Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma. Ann Surg 216:493–505PubMedCrossRef Rosen CB, Nagorney DM, Taswell HF, et al. (1992) Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma. Ann Surg 216:493–505PubMedCrossRef
37.
Zurück zum Zitat Kooby DA, Stockman J, Ben-Porat L, et al. (2003) Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases. Ann Surg 237:860–869PubMedCrossRef Kooby DA, Stockman J, Ben-Porat L, et al. (2003) Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases. Ann Surg 237:860–869PubMedCrossRef
38.
Zurück zum Zitat Elias D, Cavalcanti A, Sabourin JC, et al. (1998) Results of 136 curative hepatectomies with a safety margin of less than 10 mm for colorectal cancer. J Surg Oncol 69:88–93PubMedCrossRef Elias D, Cavalcanti A, Sabourin JC, et al. (1998) Results of 136 curative hepatectomies with a safety margin of less than 10 mm for colorectal cancer. J Surg Oncol 69:88–93PubMedCrossRef
39.
Zurück zum Zitat Pawlik TM, Scoggins CR, Zorzi D, et al. (2005) Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 241:715–722PubMedCrossRef Pawlik TM, Scoggins CR, Zorzi D, et al. (2005) Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 241:715–722PubMedCrossRef
40.
Zurück zum Zitat Bodingbauer M, Tamandl D, Schmid K, et al. (2007) Size of surgical margin does not influence recurrence rates after curative liver resection for colorectal cancer liver metastases. Br J Surg 94:1133–1138PubMedCrossRef Bodingbauer M, Tamandl D, Schmid K, et al. (2007) Size of surgical margin does not influence recurrence rates after curative liver resection for colorectal cancer liver metastases. Br J Surg 94:1133–1138PubMedCrossRef
41.
Zurück zum Zitat Bakalakos E, Kim JA, Young DC, et al. (1998) Determinants of survival following hepatic resection for metastatic colorectal cancer. World J Surg 22:399–405PubMedCrossRef Bakalakos E, Kim JA, Young DC, et al. (1998) Determinants of survival following hepatic resection for metastatic colorectal cancer. World J Surg 22:399–405PubMedCrossRef
42.
Zurück zum Zitat Mala T, Bohler G, Mathisen O, et al. (2002) Hepatic resection for colorectal metastases: can preoperative scoring predict patient outcome? World J Surg 26:1348–1353PubMedCrossRef Mala T, Bohler G, Mathisen O, et al. (2002) Hepatic resection for colorectal metastases: can preoperative scoring predict patient outcome? World J Surg 26:1348–1353PubMedCrossRef
43.
Zurück zum Zitat Jarnagin WR, Conlon K, Bodniewicz J, et al. (2001) A clinical scoring system predicts the yield of diagnostic laparoscopy in patients with potentially resectable hepatic colorectal metastases. Cancer 91:1121–1128PubMedCrossRef Jarnagin WR, Conlon K, Bodniewicz J, et al. (2001) A clinical scoring system predicts the yield of diagnostic laparoscopy in patients with potentially resectable hepatic colorectal metastases. Cancer 91:1121–1128PubMedCrossRef
Metadaten
Titel
Analysis of Prognostic Factors Influencing Long-term Survival After Hepatic Resection for Metastatic Colorectal Cancer
verfasst von
Marcella Arru
Luca Aldrighetti
Renato Castoldi
Saverio Di Palo
Elena Orsenigo
Marco Stella
Carlo Pulitanò
Francesca Gavazzi
Gianfranco Ferla
Valerio Di Carlo
Carlo Staudacher
Publikationsdatum
01.01.2008
Verlag
Springer-Verlag
Erschienen in
World Journal of Surgery / Ausgabe 1/2008
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-007-9285-y

Weitere Artikel der Ausgabe 1/2008

World Journal of Surgery 1/2008 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.